About
Overview
Catalyst is a biopharmaceutical company focused on protease therapeutics to address unmet medical needs in disorders of the coagulation systems. Catalyst’s product candidates consist of the coagulation related assets marzeptacog alfa (activated) (“MarzAA”), dalcinonacog alfa (“DalcA”), and
Management Team
We have assembled an experienced leadership team including world-class scientists, advisors, and collaborators. We have established, and continue to expand, a robust
Nassim Usman, Ph.D.
President and Chief Executive Officer
Seline Miller, CPA
Senior Vice President, Finance
Interim Chief Financial Officer & Interim Principal Accounting Officer
Board
We have assembled an experienced leadership team including world-class scientists, advisors, and collaborators. We have established, and continue to expand, a robust
Augustine Lawlor, Chairman of the Board
Managing Director, HealthCare Ventures LLC
Thomas Eastling
Board Member and
Chief Financial Officer,
Cullgen Inc.
Andrea Hunt
Chair of G&N Committee, Member of Board of Directors, Catalyst Biosciences, Inc.
Ying Luo, Ph.D.
President and CEO,
GNI Group
President and CEO,
Cullgen Inc.
Nassim Usman, Ph.D.
President and Chief Executive Officer, Catalyst Biosciences, Inc.